This treatment would work by targeting the SARS-CoV-2 virus itself and stopping it in its tracks. The evidence we have so far is promising, but it’s still very early days.
Articles on Pfizer
Displaying 61 - 80 of 116 articles
The COVID-19 variant responsible for Victoria’s latest outbreak is one of three Indian variant sub-types, which spreads more easily than the original strain. Here’s what we know so far.
The Pfizer COVID-19 vaccine was recently approved for adolescents ages 12-15. Vaccination is essential to protect children from serious illness and quicken return to normal life.
Canadian public health organizations have run into a serious communication problem about the AstraZeneca vaccine. Crisis management and communication theories explain what’s gone wrong.
Skyrocketing demand coupled with shortages of vital components is leading to bottlenecks in the supply chain of Pfizer’s and other mRNA vaccines.
Our best long-term strategy is to rely on the mRNA vaccines like Pfizer and Moderna.
Australia was promised a world-class vaccine program. But instead of a rollout, we got an eekout.
The amount of risk from overseas arrivals depends not just on Australia’s vaccination rates, but also on the particular circumstances of the country from which people are travelling.
Generally speaking, fault can only be proven when the doctor has acted outside of the professional standard of care.
This shift in focus away from AstraZeneca to the Pfizer vaccine has serious impacts on the timing of the rollout and public confidence in the AstraZeneca vaccine.
These mistakes have been mainly caused by our leaders giving priority to a good political story over good policy.
So far, most vaccines in the US are mRNA vaccines. These represent a new technology and are likely to take over the vaccine world. But how do they work? What are their weaknesses? Five experts explain.
The coronavirus pandemic has driven a lot of scientific progress in the past year. But just as some of the social changes are likely here to stay, so are some medical innovations.
The Johnson & Johnson vaccine is different from the Moderna and Pfizer vaccines in a few important ways that could make it a huge help to global vaccination efforts.
With the vaccines now being administered at sites around the US, it is important to address misinformation surrounding the effort.
The clock starts ticking once the vaccine leaves the freezer. Here’s what to expect.
Behind Canada’s current COVID-19 vaccine shortage is a decades-long tale of unheeded warnings, missed opportunities and dismantled resources that was never going to end well.
Americans with excess weight and obesity have been hit hard by COVID-19. Now there is reason to believe they may not get the same protection from the vaccines.
It’s going to be a huge logistical challenge.
Production limits the rate at which vaccines can be rolled out, and is at the heart of the current disagreements between the UK and EU.
Top contributors
-
Associate Professor and ARC Future Fellow, The University of Western Australia
-
Professor, The Children's Hospital at Westmead Clinical School and Sydney Infectious Diseases Institute, University of Sydney
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professor of Medicine, University of Virginia
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professorial Fellow, University of Canberra
-
Instructor of Human Immunology, Emory University
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor, Infectious Diseases and Microbiology, The University of Queensland
-
Professor of Paediatrics and vaccinologist, Royal Childrens Hospital, University of Melbourne and Murdoch Childrens Research Institute (MCRI); Associate Dean International, University of Melbourne, Murdoch Children's Research Institute
-
Pharmacist and PhD Candidate, University of Sydney
-
Pediatric Infectious Diseases Fellow, University of Pittsburgh
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Professor of Business, University of Michigan